Page last updated: 2024-08-22

magnesium sulfate and Adenocarcinoma, Basal Cell

magnesium sulfate has been researched along with Adenocarcinoma, Basal Cell in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's5 (55.56)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atkins, CD1
Bo, A; Chi, B; Su, X; Sun, J; Xia, Y; Zhang, X1
Ban, M; Kim, JE; Kim, SY; Lee, HS; Lee, YC; Shin, CS1
Alberts, SR; Chitaley, U; Dentchev, T; Grothey, A; Kugler, JW; Loprinzi, CL; Nikcevich, DA; Novotny, PJ; Silberstein, PT; Sloan, JA; Wender, DB1
Chan, A; Chay, WY; Chiang, J; Lew, KY1
Donovan, CT; Ferencz, TM; McGurk, ML; Saif, MW; Wrzesinski, SH1
Hashmi, S; Saif, MW1
Asmar, L; Boehm, KA; McCollum, D; Richards, D; Sborov, M; Wilfong, L; Zhan, F1
Chambers, JC1

Trials

3 trial(s) available for magnesium sulfate and Adenocarcinoma, Basal Cell

ArticleYear
Beneficial effect of intravenous magnesium during endoscopic submucosal dissection for gastric neoplasm.
    Surgical endoscopy, 2015, Volume: 29, Issue:12

    Topics: Abdominal Pain; Adenocarcinoma; Adenoma; Adult; Aged; Aged, 80 and over; Analgesics; Dissection; Double-Blind Method; Female; Gastric Mucosa; Gastroscopy; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Magnesium Sulfate; Male; Middle Aged; Pain, Postoperative; Prospective Studies; Stomach Neoplasms; Treatment Outcome

2015
Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Feb-01, Volume: 29, Issue:4

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Calcium Gluconate; Chemotherapy, Adjuvant; Chi-Square Distribution; Colonic Neoplasms; Double-Blind Method; Drug Combinations; Early Termination of Clinical Trials; Female; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Magnesium Sulfate; Male; Middle Aged; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Prospective Studies; Sensation Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome

2011
Phase II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer and/or adenocarcinoma of the gastroesophageal junction.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Dexamethasone; Disease-Free Survival; Docetaxel; Esophagogastric Junction; Female; Gastrointestinal Diseases; Humans; Magnesium Sulfate; Male; Middle Aged; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Premedication; Stomach Neoplasms; Taxoids; Treatment Outcome

2008

Other Studies

6 other study(ies) available for magnesium sulfate and Adenocarcinoma, Basal Cell

ArticleYear
Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Oct-10, Volume: 32, Issue:29

    Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Calcium; Calcium Gluconate; Colonic Neoplasms; Female; Humans; Magnesium; Magnesium Sulfate; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Organoplatinum Compounds; Peripheral Nervous System Diseases; Sensation Disorders

2014
Magnesium sulfate induced toxicity in vitro in AGS gastric adenocarcinoma cells and in vivo in mouse gastric mucosa.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:1

    Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Food Additives; Gastric Mucosa; Gene Expression; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Magnesium Sulfate; Mice; Mice, Inbred BALB C; Stomach Neoplasms; Tumor Necrosis Factor-alpha

2015
Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-01, Volume: 29, Issue:16

    Topics: Adenocarcinoma; Antineoplastic Agents; Calcium Gluconate; Clinical Trials as Topic; Colonic Neoplasms; Early Termination of Clinical Trials; Humans; Infusions, Intravenous; Magnesium Sulfate; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Research Design; Sensory Receptor Cells

2011
Successful desensitization to oxaliplatin with incorporation of calcium gluconate and magnesium sulfate.
    Anti-cancer drugs, 2007, Volume: 18, Issue:6

    Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Calcium Gluconate; Drug Hypersensitivity; Female; Fluorouracil; Humans; Leucovorin; Magnesium Sulfate; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Sigmoid Neoplasms; Treatment Outcome

2007
Successful amelioration of oxaliplatin-induced hyperexcitability syndrome with the antiepileptic pregabalin in a patient with pancreatic cancer.
    Cancer chemotherapy and pharmacology, 2008, Volume: 61, Issue:3

    Topics: Adenocarcinoma; Adult; Anticonvulsants; Antimetabolites, Antineoplastic; Antineoplastic Agents; Calcium Gluconate; Deoxycytidine; Diphenhydramine; Female; gamma-Aminobutyric Acid; Gemcitabine; Histamine H1 Antagonists; Humans; Magnesium Sulfate; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Pregabalin; Psychomotor Agitation

2008
Magnesium sulfate via a mucous fistula in the management of short bowel syndrome.
    Journal of pain and symptom management, 2008, Volume: 35, Issue:6

    Topics: Adenocarcinoma; Colonic Neoplasms; Fatal Outcome; Fistula; Humans; Ileostomy; Ileum; Magnesium Deficiency; Magnesium Sulfate; Male; Middle Aged; Mucous Membrane; Short Bowel Syndrome

2008